| Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review S Shahmohammadi, R Doosti, A Shahmohammadi, ... Multiple sclerosis and related disorders 27, 350-363, 2019 | 141 | 2019 |
| Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis MA Sahraian, A Azimi, S Navardi, S Ala, AN Moghadasi Multiple sclerosis and related disorders 46, 102472, 2020 | 92 | 2020 |
| Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients FH Akhoundi, MA Sahraian, AN Moghadasi Multiple sclerosis and related disorders 41, 102164, 2020 | 58 | 2020 |
| Epidemiology of multiple sclerosis in Qom: Demographic study in Iran S Rezaali, A Khalilnezhad, AN Moghadasi, S Chaibakhsh, MA Sahraian Iranian journal of neurology 12 (4), 136, 2013 | 58 | 2013 |
| Autoimmune encephalitis associated with COVID-19: A systematic review F Nabizadeh, M Balabandian, F Sodeifian, N Rezaei, MR Rostami, ... Multiple Sclerosis and Related Disorders 62, 103795, 2022 | 54 | 2022 |
| Neuromyelitis optica spectrum disorders in Iran SMA Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN Mult Scler Relat Disord 18, 209-212, 2017 | 53 | 2017 |
| Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis M Azimi, M Ghabaee, AN Moghadasi, F Noorbakhsh, M Izad Immunologic Research 66, 513-520, 2018 | 50 | 2018 |
| The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis AN Moghadasi, O Mirmosayyeb, M Barzegar, MA Sahraian, ... Neurological sciences 42 (8), 3093-3099, 2021 | 42 | 2021 |
| Altered Expression of miR-326 in T Cell-derived Exosomes of Patients with Relapsing-remitting Multiple Sclerosis. IM Azimi M, Ghabaee M, Naser Moghadasi A Iran J Allergy Asthma Immunol 18 (1), 108-113, 2019 | 42 | 2019 |
| One aspect of coronavirus disease (COVID-19) outbreak in Iran: high anxiety among MS patients AN Moghadasi Multiple sclerosis and related disorders 41, 102138, 2020 | 40 | 2020 |
| Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set S Shahin, S Eskandarieh, AN Moghadasi, N Razazian, SM Baghbanian, ... Multiple sclerosis and related disorders 33, 158-161, 2019 | 39 | 2019 |
| Diagnosis and management of neuromyelitis optica spectrum disorder (NMOSD) in Iran: a consensus guideline and recommendations MA Sahraian, AN Moghadasi, AR Azimi, N Asgari, FH Akhoundi, ... Multiple sclerosis and related disorders 18, 144-151, 2017 | 39 | 2017 |
| Environmental risk factors in neuromyelitis optica spectrum disorder: a case–control study S Eskandarieh, S Nedjat, I Abdollahpour, AR Azimi, AN Moghadasi, ... Acta Neurologica Belgica 118, 277-287, 2018 | 38 | 2018 |
| Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV MA Sahraian, F Ghadiri, A Azimi, AN Moghadasi Vaccine 39 (43), 6347-6350, 2021 | 37 | 2021 |
| Relationship between sleep quality and quality of life in patients with multiple sclerosis P Sarraf, S Azizi, AN Moghaddasi, MA Sahraian, A Tafakhori, ... International Journal of Preventive Medicine 5 (12), 1582, 2014 | 37 | 2014 |
| Artificial eye in burnt city and theoretical understanding of how vision works AN Moghadasi Iranian journal of public health 43 (11), 1595, 2014 | 35 | 2014 |
| Sleep disorder as a triggering factor for relapse in multiple sclerosis MA Sahraian, S Rezaali, M Hosseiny, R Doosti, A Tajik, ... European Neurology 77 (5-6), 258-261, 2017 | 34 | 2017 |
| Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran MA Sahraian, MR Gheini, N Rezaeimanesh, M Ghajarzadeh, ... Multiple sclerosis and related disorders 42, 102193, 2020 | 33 | 2020 |
| The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran S Eskandarieh, N Molazadeh, AN Moghadasi, AR Azimi, MA Sahraian Multiple sclerosis and related disorders 25, 143, 2018 | 33 | 2018 |
| The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients H Noori, MR Gheini, N Rezaeimanesh, R Saeedi, HR Aliabadi, ... Multiple Sclerosis and Related Disorders 36, 101415, 2019 | 32 | 2019 |
